Polarization of Vδ2 T cells to a Th2-like phenotype promotes plasmablast differentiation and possesses pro-fibrotic properties in IgG4-related disease

To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD). Flow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 16; p. 1550405
Main Authors Li, Jieqiong, Wang, Mu, Zhou, Jiaxin, Fei, Yunyun, Li, Mengtao, Zhao, Yan, Zeng, Xiaofeng, Peng, Linyi, Zhang, Wen
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 27.03.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD). Flow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription factor profiles. Immunofluorescence assessed Vδ2 T cell infiltration in affected tissues. Chemotaxis assays and co-culture experiments investigated Vδ2 T cell migration and their influence on B cell differentiation. The impact of IL-21 stimulation and JAK/STAT3 inhibitors on γδ T cell was also evaluated. Patients with IgG4-RD exhibited decreased peripheral Vδ2 T cells displaying a Th2-like phenotype characterized by elevated Th2 cytokine production and activated IL-21-STAT3-Blimp-1-GATA3 pathway. Vδ2 T cells accumulated in affected tissues through CCR7 upregulation, and co-localizing with B cells. Both Vδ2 T cells and culture supernatants from IgG4-RD patients promoted B cell differentiation. IL-21 stimulation augmented pSTAT3, Blimp-1, and GATA3 expression in Vδ2 T cells, while JAK and STAT3 inhibitors attenuated these effects. IgG4-RD patients exhibited increased TGF-β and pro-fibrotic gene expression in γδ T cells. Within the IL-21-rich microenvironment of IgG4-RD, peripheral Vδ2 T cells acquire a Th2-like phenotype via the IL-21-STAT3-Blimp-1-GATA3 pathway. Targeting JAK/STAT3 inhibitors holds therapeutic potential for IgG4-RD.
AbstractList To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD). Flow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription factor profiles. Immunofluorescence assessed Vδ2 T cell infiltration in affected tissues. Chemotaxis assays and co-culture experiments investigated Vδ2 T cell migration and their influence on B cell differentiation. The impact of IL-21 stimulation and JAK/STAT3 inhibitors on γδ T cell was also evaluated. Patients with IgG4-RD exhibited decreased peripheral Vδ2 T cells displaying a Th2-like phenotype characterized by elevated Th2 cytokine production and activated IL-21-STAT3-Blimp-1-GATA3 pathway. Vδ2 T cells accumulated in affected tissues through CCR7 upregulation, and co-localizing with B cells. Both Vδ2 T cells and culture supernatants from IgG4-RD patients promoted B cell differentiation. IL-21 stimulation augmented pSTAT3, Blimp-1, and GATA3 expression in Vδ2 T cells, while JAK and STAT3 inhibitors attenuated these effects. IgG4-RD patients exhibited increased TGF-β and pro-fibrotic gene expression in γδ T cells. Within the IL-21-rich microenvironment of IgG4-RD, peripheral Vδ2 T cells acquire a Th2-like phenotype via the IL-21-STAT3-Blimp-1-GATA3 pathway. Targeting JAK/STAT3 inhibitors holds therapeutic potential for IgG4-RD.
ObjectivesTo explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD).MethodsFlow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription factor profiles. Immunofluorescence assessed Vδ2 T cell infiltration in affected tissues. Chemotaxis assays and co-culture experiments investigated Vδ2 T cell migration and their influence on B cell differentiation. The impact of IL-21 stimulation and JAK/STAT3 inhibitors on γδ T cell was also evaluated.ResultsPatients with IgG4-RD exhibited decreased peripheral Vδ2 T cells displaying a Th2-like phenotype characterized by elevated Th2 cytokine production and activated IL-21—STAT3—Blimp-1—GATA3 pathway. Vδ2 T cells accumulated in affected tissues through CCR7 upregulation, and co-localizing with B cells. Both Vδ2 T cells and culture supernatants from IgG4-RD patients promoted B cell differentiation. IL-21 stimulation augmented pSTAT3, Blimp-1, and GATA3 expression in Vδ2 T cells, while JAK and STAT3 inhibitors attenuated these effects. IgG4-RD patients exhibited increased TGF-β and pro-fibrotic gene expression in γδ T cells.ConclusionWithin the IL-21-rich microenvironment of IgG4-RD, peripheral Vδ2 T cells acquire a Th2-like phenotype via the IL-21—STAT3—Blimp-1—GATA3 pathway. Targeting JAK/STAT3 inhibitors holds therapeutic potential for IgG4-RD.
To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD).ObjectivesTo explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD).Flow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription factor profiles. Immunofluorescence assessed Vδ2 T cell infiltration in affected tissues. Chemotaxis assays and co-culture experiments investigated Vδ2 T cell migration and their influence on B cell differentiation. The impact of IL-21 stimulation and JAK/STAT3 inhibitors on γδ T cell was also evaluated.MethodsFlow cytometry and quantitative RT-PCR were employed to analyze γδ T cell subsets, chemokine receptor expression, cytokine production, pro-fibrotic gene expression, and transcription factor profiles. Immunofluorescence assessed Vδ2 T cell infiltration in affected tissues. Chemotaxis assays and co-culture experiments investigated Vδ2 T cell migration and their influence on B cell differentiation. The impact of IL-21 stimulation and JAK/STAT3 inhibitors on γδ T cell was also evaluated.Patients with IgG4-RD exhibited decreased peripheral Vδ2 T cells displaying a Th2-like phenotype characterized by elevated Th2 cytokine production and activated IL-21-STAT3-Blimp-1-GATA3 pathway. Vδ2 T cells accumulated in affected tissues through CCR7 upregulation, and co-localizing with B cells. Both Vδ2 T cells and culture supernatants from IgG4-RD patients promoted B cell differentiation. IL-21 stimulation augmented pSTAT3, Blimp-1, and GATA3 expression in Vδ2 T cells, while JAK and STAT3 inhibitors attenuated these effects. IgG4-RD patients exhibited increased TGF-β and pro-fibrotic gene expression in γδ T cells.ResultsPatients with IgG4-RD exhibited decreased peripheral Vδ2 T cells displaying a Th2-like phenotype characterized by elevated Th2 cytokine production and activated IL-21-STAT3-Blimp-1-GATA3 pathway. Vδ2 T cells accumulated in affected tissues through CCR7 upregulation, and co-localizing with B cells. Both Vδ2 T cells and culture supernatants from IgG4-RD patients promoted B cell differentiation. IL-21 stimulation augmented pSTAT3, Blimp-1, and GATA3 expression in Vδ2 T cells, while JAK and STAT3 inhibitors attenuated these effects. IgG4-RD patients exhibited increased TGF-β and pro-fibrotic gene expression in γδ T cells.Within the IL-21-rich microenvironment of IgG4-RD, peripheral Vδ2 T cells acquire a Th2-like phenotype via the IL-21-STAT3-Blimp-1-GATA3 pathway. Targeting JAK/STAT3 inhibitors holds therapeutic potential for IgG4-RD.ConclusionWithin the IL-21-rich microenvironment of IgG4-RD, peripheral Vδ2 T cells acquire a Th2-like phenotype via the IL-21-STAT3-Blimp-1-GATA3 pathway. Targeting JAK/STAT3 inhibitors holds therapeutic potential for IgG4-RD.
Author Peng, Linyi
Zhou, Jiaxin
Li, Mengtao
Zeng, Xiaofeng
Wang, Mu
Li, Jieqiong
Fei, Yunyun
Zhao, Yan
Zhang, Wen
AuthorAffiliation 2 Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing , China
1 Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, The Ministry of Education Key Laboratory , Beijing , China
AuthorAffiliation_xml – name: 1 Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, State Key Laboratory of Complex Severe and Rare Diseases, The Ministry of Education Key Laboratory , Beijing , China
– name: 2 Department of Stomatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Beijing , China
Author_xml – sequence: 1
  givenname: Jieqiong
  surname: Li
  fullname: Li, Jieqiong
– sequence: 2
  givenname: Mu
  surname: Wang
  fullname: Wang, Mu
– sequence: 3
  givenname: Jiaxin
  surname: Zhou
  fullname: Zhou, Jiaxin
– sequence: 4
  givenname: Yunyun
  surname: Fei
  fullname: Fei, Yunyun
– sequence: 5
  givenname: Mengtao
  surname: Li
  fullname: Li, Mengtao
– sequence: 6
  givenname: Yan
  surname: Zhao
  fullname: Zhao, Yan
– sequence: 7
  givenname: Xiaofeng
  surname: Zeng
  fullname: Zeng, Xiaofeng
– sequence: 8
  givenname: Linyi
  surname: Peng
  fullname: Peng, Linyi
– sequence: 9
  givenname: Wen
  surname: Zhang
  fullname: Zhang, Wen
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40213561$$D View this record in MEDLINE/PubMed
BookMark eNpVkt9uFCEUxiemxtbaF_DCcOnNrPydgStjGq2bNNGL1VvCMIdd6swwAtukvogv4nP4TDLdtWkJgQN8_A7hfC-rkylMUFWvCV4xJtU758dxv6KYihURAnMsnlVnpGl4zSjlJ4_i0-oipRtcGleMMfGiOuWYEiYaclb9_hoGE_0vk32YUHDo-98_FG2QhWFIKAdk0GZH68H_ADTvYAr5bi5RDGPIkNA8mDSarowZ9d45iDBlf4CZqUdzSAmWvlypne9iyN4uixli9mXfT2i9veJ1hMFk6AslgUnwqnruzJDg4jifV98-fdxcfq6vv1ytLz9c15ZTmmtnuesFYEcVl5JhCx2XDe77hrQGKwyGtgxLq5h1DYGuA2ixIZZ3vZANcHZerQ_cPpgbPUc_mning_H6fiPErTbloXYA3VjKW8aFVJhz46iUCqQi2HFOcOu6wnp_YM37boTelq-IZngCfXoy-Z3ehltNiJKsIbQQ3h4JMfzcQ8p69GkphZkg7JNmREpJscCqSN88TvaQ5X9pi4AeBDaWIkRwDxKC9WIhfW8hvVhIHy3E_gG8Gr2D
Cites_doi 10.1038/srep14432
10.1016/j.jaut.2019.01.013
10.1155/2022/2814510
10.3389/fimmu.2021.693192
10.1146/annurev-immunol-032713-120216
10.4049/jimmunol.172.4.2059
10.1136/annrheumdis-2019-216561
10.1126/science.aay5516
10.1093/intimm/dxn059
10.1038/cmi.2012.26
10.1007/s00005-021-00608-7
10.1016/j.cellimm.2021.104420
10.1002/art.2018.70.issue-11
10.1016/j.ejphar.2021.174510
10.5041/RMMJ.10256
10.1038/s41467-021-21246-9
10.1002/art.2019.71.issue-3
10.3390/cells9040800
10.55563/clinexprheumatol/61mt03
10.1016/j.jaci.2019.07.004
10.1136/annrheumdis-2016-211069
10.1007/s10059-013-0154-2
10.1016/j.biopha.2016.10.083
10.1002/eji.201142017
10.3389/fimmu.2021.627139
10.1126/sciimmunol.aat1604
10.1016/j.anai.2018.02.012
10.4049/jimmunol.1700826
10.1002/art.42043
10.1186/s13075-019-2069-6
10.1016/j.gastrohep.2019.08.009
10.1371/journal.pone.0041940
10.1084/jem.20190742
10.3389/fimmu.2018.02389
10.3389/fimmu.2014.00607
10.1093/rheumatology/kez667
10.1038/s41590-020-0706-5
10.1590/S1679-45082015RB3438
10.3390/cells9030743
10.1080/08916934.2019.1693545
10.1016/j.imlet.2020.03.007
ContentType Journal Article
Copyright Copyright © 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang.
Copyright © 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang
Copyright_xml – notice: Copyright © 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang.
– notice: Copyright © 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2025.1550405
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_6c24734589044af2889e8910f44107fb
PMC11983612
40213561
10_3389_fimmu_2025_1550405
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IPNFZ
M48
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c422t-fc4fd5e0f2948830ceb4860dd617a090ea27308c93cf61ebbee70a1c4bd586e43
IEDL.DBID DOA
ISSN 1664-3224
IngestDate Wed Aug 27 01:31:48 EDT 2025
Thu Aug 21 18:26:12 EDT 2025
Fri Apr 11 19:19:46 EDT 2025
Tue Apr 15 01:23:14 EDT 2025
Tue Jul 01 05:13:50 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Th2-like phenotype
plasmablasts
IgG4-related disease
IL-21–STAT3
Vδ2 T cells
Language English
License Copyright © 2025 Li, Wang, Zhou, Fei, Li, Zhao, Zeng, Peng and Zhang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c422t-fc4fd5e0f2948830ceb4860dd617a090ea27308c93cf61ebbee70a1c4bd586e43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Shaozhe Cai, Huazhong University of Science and Technology, China
Josna Joseph, Christian Medical College and Hospital, India
Edited by: Stefan Tukaj, University of Gdansk, Poland
OpenAccessLink https://doaj.org/article/6c24734589044af2889e8910f44107fb
PMID 40213561
PQID 3188820509
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_6c24734589044af2889e8910f44107fb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11983612
proquest_miscellaneous_3188820509
pubmed_primary_40213561
crossref_primary_10_3389_fimmu_2025_1550405
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-03-27
PublicationDateYYYYMMDD 2025-03-27
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-27
  day: 27
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2025
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References (B6) 2016; 7
Liu (B18) 2022; 2022
Ferrari-Lacraz (B41) 2008; 20
Rampoldi (B10) 2020; 9
Rigau (B37) 2020; 367
Fichtner (B8) 2020; 9
Wallace (B19) 2020; 79
Eivazi (B29) 2016; 84
Chinju (B4) 2022; 74
Chien (B7) 2014; 32
Lloyd (B17) 2018; 3
Zarobkiewicz (B9) 2021; 69
Jin (B15) 2021; 12
He (B30) 2020; 217
Bansal (B11) 2012; 42
Presti (B33) 2014; 5
Liu (B16) 2021; 368
Ong (B21) 2021; 911
Maritati (B2) 2020; 59
Mo (B27) 2017; 76
Yusoff (B20) 2020; 53
Shiromizu (B34) 2018; 9
Wang (B38) 2019; 21
Palomino (B26) 2015; 13
Caccamo (B35) 2012; 7
Hwang (B14) 2013; 36
Yin (B32) 2015; 5
Mirlekar (B23) 2020; 222
Sánchez-Oro (B1) 2019; 42
Cao (B31) 2024; 42
Rosser (B40) 2019; 71
Chen (B13) 2018; 70
Choi (B24) 2020; 21
Chen (B25) 2004; 172
Howell (B36) 2018; 120
Michailidou (B3) 2021; 12
Qi (B5) 2021; 12
Shekhar (B28) 2012; 9
Long (B12) 2019; 99
Della-Torre (B22) 2020; 145
Campbell (B39) 2017; 199
References_xml – volume: 5
  start-page: 14432
  year: 2015
  ident: B32
  article-title: Hyperactivation and in situ recruitment of inflammatory Vδ2 T cells contributes to disease pathogenesis in systemic lupus erythematosus
  publication-title: Sci Rep
  doi: 10.1038/srep14432
– volume: 99
  start-page: 1
  year: 2019
  ident: B12
  article-title: Clinical significance and immunobiology of IL-21 in autoimmunity
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.01.013
– volume: 2022
  start-page: 2814510
  year: 2022
  ident: B18
  article-title: Bach2: A key regulator in th2-related immune cells and th2 immune response
  publication-title: J Immunol Res
  doi: 10.1155/2022/2814510
– volume: 12
  year: 2021
  ident: B3
  article-title: Allergic aspects of igG4-related disease: implications for pathogenesis and therapy
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.693192
– volume: 32
  year: 2014
  ident: B7
  article-title: [amp]]gamma;δ T cells: first line of defense and beyond
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032713-120216
– volume: 172
  year: 2004
  ident: B25
  article-title: IL-4 induces differentiation and expansion of Th2 cytokine-producing eosinophils
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.4.2059
– volume: 79
  start-page: 77
  year: 2020
  ident: B19
  article-title: The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216561
– volume: 367
  year: 2020
  ident: B37
  article-title: Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
  publication-title: Science
  doi: 10.1126/science.aay5516
– volume: 20
  year: 2008
  ident: B41
  article-title: IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxn059
– volume: 9
  year: 2012
  ident: B28
  article-title: The darker side of follicular helper T cells: from autoimmunity to immunodeficiency
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2012.26
– volume: 69
  start-page: 4
  year: 2021
  ident: B9
  article-title: γδ T lymphocytes in asthma: a complicated picture
  publication-title: Arch Immunol Ther Exp (Warsz)
  doi: 10.1007/s00005-021-00608-7
– volume: 368
  start-page: 104420
  year: 2021
  ident: B16
  article-title: Distinct roles of ICOS and CD40L in human T-B cell adhesion and antibody production
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2021.104420
– volume: 70
  year: 2018
  ident: B13
  article-title: Aberrant expansion and function of follicular helper T cell subsets in igG4-related disease
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.2018.70.issue-11
– volume: 911
  start-page: 174510
  year: 2021
  ident: B21
  article-title: TGF-β-induced fibrosis: A review on the underlying mechanism and potential therapeutic strategies
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2021.174510
– volume: 7
  start-page: e0029
  year: 2016
  ident: B6
  article-title: The role of γδ T cells in fibrotic diseases
  publication-title: Rambam Maimonides Med J
  doi: 10.5041/RMMJ.10256
– volume: 12
  start-page: 1088
  year: 2021
  ident: B15
  article-title: Inference and analysis of cell-cell communication using CellChat
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21246-9
– volume: 71
  year: 2019
  ident: B40
  article-title: Innate lymphoid cells and T cells contribute to the interleukin-17A signature detected in the synovial fluid of patients with juvenile idiopathic arthritis
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.2019.71.issue-3
– volume: 9
  start-page: 800
  year: 2020
  ident: B8
  article-title: Human γδ TCR repertoires in health and disease
  publication-title: Cells
  doi: 10.3390/cells9040800
– volume: 42
  year: 2024
  ident: B31
  article-title: Effectiveness of tofacitinib monotherapy for patients with IgG4-RD or idiopathic retroperitoneal fibrosis
  publication-title: Clin Exp Rheumatol
  doi: 10.55563/clinexprheumatol/61mt03
– volume: 145
  start-page: 968
  year: 2020
  ident: B22
  article-title: B lymphocytes directly contribute to tissue fibrosis in patients with IgG(4)-related disease
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2019.07.004
– volume: 76
  year: 2017
  ident: B27
  article-title: Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-211069
– volume: 36
  year: 2013
  ident: B14
  article-title: Cell-cell communication via extracellular membrane vesicles and its role in the immune response
  publication-title: Mol Cells
  doi: 10.1007/s10059-013-0154-2
– volume: 84
  year: 2016
  ident: B29
  article-title: Development of T follicular helper cells and their role in disease and immune system
  publication-title: BioMed Pharmacother
  doi: 10.1016/j.biopha.2016.10.083
– volume: 42
  year: 2012
  ident: B11
  article-title: IL-21 enhances the potential of human γδ T cells to provide B-cell help
  publication-title: Eur J Immunol
  doi: 10.1002/eji.201142017
– volume: 12
  year: 2021
  ident: B5
  article-title: Gamma delta T cells and their pathogenic role in psoriasis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.627139
– volume: 3
  year: 2018
  ident: B17
  article-title: Snelgrove. Type 2 immunity: Expanding our view
  publication-title: Sci Immunol
  doi: 10.1126/sciimmunol.aat1604
– volume: 120
  year: 2018
  ident: B36
  article-title: JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/j.anai.2018.02.012
– volume: 199
  year: 2017
  ident: B39
  article-title: IL-17-secreting γδ T cells are completely dependent upon CCR6 for homing to inflamed skin
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1700826
– volume: 74
  start-page: 892
  year: 2022
  ident: B4
  article-title: CD163+ M2 macrophages promote fibrosis in igG4-related disease via toll-like receptor 7/interleukin-1 receptor-associated kinase 4/NF-κB signaling
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.42043
– volume: 21
  start-page: 295
  year: 2019
  ident: B38
  article-title: High-throughput sequencing of CD4(+) T cell repertoire reveals disease-specific signatures in IgG4-related disease
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-019-2069-6
– volume: 42
  year: 2019
  ident: B1
  article-title: Review of igG4-related disease
  publication-title: Gastroenterol Hepatol
  doi: 10.1016/j.gastrohep.2019.08.009
– volume: 7
  year: 2012
  ident: B35
  article-title: IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity
  publication-title: PloS One
  doi: 10.1371/journal.pone.0041940
– volume: 217
  year: 2020
  ident: B30
  article-title: Blimp-1 is essential for allergen-induced asthma and Th2 cell development in the lung
  publication-title: J Exp Med
  doi: 10.1084/jem.20190742
– volume: 9
  year: 2018
  ident: B34
  article-title: [amp]]gamma;δ T lymphocytes: an effector cell in autoimmunity and infection
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.02389
– volume: 5
  year: 2014
  ident: B33
  article-title: Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance, and differential programing in the tumor microenvironment
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2014.00607
– volume: 59
  year: 2020
  ident: B2
  article-title: IgG4-related disease: a clinical perspective
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kez667
– volume: 21
  year: 2020
  ident: B24
  article-title: Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits
  publication-title: Nat Immunol
  doi: 10.1038/s41590-020-0706-5
– volume: 13
  year: 2015
  ident: B26
  article-title: Chemokines and immunity
  publication-title: Einstein (Sao Paulo)
  doi: 10.1590/S1679-45082015RB3438
– volume: 9
  start-page: 743
  year: 2020
  ident: B10
  article-title: Revisiting the interaction of γδ T-cells and B-cells
  publication-title: Cells
  doi: 10.3390/cells9030743
– volume: 53
  start-page: 8
  year: 2020
  ident: B20
  article-title: Th1, Th2, and Th17 cytokines in systemic lupus erythematosus
  publication-title: Autoimmunity
  doi: 10.1080/08916934.2019.1693545
– volume: 222
  start-page: 58
  year: 2020
  ident: B23
  article-title: Co-expression of master transcription factors determines CD4(+) T cell plasticity and functions in auto-inflammatory diseases
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2020.03.007
SSID ssj0000493335
Score 2.3971305
Snippet To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD). Flow cytometry and quantitative RT-PCR...
To explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD).ObjectivesTo explore the phenotype and role...
ObjectivesTo explore the phenotype and role of gamma delta (γδ) T cells in the pathogenesis of IgG4-related disease (IgG4-RD).MethodsFlow cytometry and...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 1550405
SubjectTerms Aged
Cell Differentiation - immunology
Cytokines - metabolism
Female
Fibrosis
GATA3 Transcription Factor - metabolism
Humans
IgG4-related disease
IL-21–STAT3
Immunoglobulin G4-Related Disease - immunology
Immunoglobulin G4-Related Disease - metabolism
Immunoglobulin G4-Related Disease - pathology
Immunology
Interleukin-21
Interleukins - metabolism
Lymphocyte Activation
Male
Middle Aged
Phenotype
Plasma Cells - immunology
Plasma Cells - metabolism
plasmablasts
Receptors, Antigen, T-Cell, gamma-delta - immunology
Receptors, Antigen, T-Cell, gamma-delta - metabolism
T-Lymphocyte Subsets - immunology
T-Lymphocyte Subsets - metabolism
Th2 Cells - immunology
Th2 Cells - metabolism
Th2-like phenotype
Vδ2 T cells
Title Polarization of Vδ2 T cells to a Th2-like phenotype promotes plasmablast differentiation and possesses pro-fibrotic properties in IgG4-related disease
URI https://www.ncbi.nlm.nih.gov/pubmed/40213561
https://www.proquest.com/docview/3188820509
https://pubmed.ncbi.nlm.nih.gov/PMC11983612
https://doaj.org/article/6c24734589044af2889e8910f44107fb
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kQfAivo2uSwveJG7SjyR9XGUfCoqHWZlb6Ee1O-okYSdz2F_iH_F37G-yKsksMyJ48RJIpyFNf9VdX3XXg7FXUrlSQVGlhdMiRaEwqXVUEtD43CE_D0ZT7PDHT8XZufow1_OtUl_kEzamBx4n7rDwQpVS6cpkStkoqspAhTouoh7Pyuho90Wdt2VMfRt5r5RSj1EyaIWZw7hYLtdoDwr9hli5onp1W5poSNj_N5b5p7PklvY5ucfuTrSRH43Dvc9uQfOA3R4LSV49ZD8_k4U6hVTyNvIv178En3E6ll_xvuWWzy5E-mPxHTg5dbV08sq7wRUPVrxDCr20Dp8931RM6UfMuG0C79rhaph6XrZpRAu7xXHQS0du2di-aPj7r6cqHUJjIPDp3ucROz85nr07S6eSC6lXQvRp9CoGDVkUBle2zDw4qlIVAhIdm5kMLNKdrPJG-ljk4BxAmdncKxd0VYCSj9le0zbwlPHcBiui8KUuvQqgDRTO5lbrMBx-QcJeb6a_7sbMGjVaJARWPYBVE1j1BFbC3hJCNz0pK_bQgLJST7JS_0tWEvZyg2-Nq4gwsA2061WNOxuaGpQLJ2FPRrxvfoUWdi6RZias2pGEnbHsfmkWF0Om7jw3lUQO-ex_jP45u0MzQg5wotxne_3lGl4gI-rdwSD8-Dyd578BYbIMRA
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polarization+of+V%CE%B42+T+cells+to+a+Th2-like+phenotype+promotes+plasmablast+differentiation+and+possesses+pro-fibrotic+properties+in+IgG4-related+disease&rft.jtitle=Frontiers+in+immunology&rft.au=Jieqiong+Li&rft.au=Mu+Wang&rft.au=Jiaxin+Zhou&rft.au=Yunyun+Fei&rft.date=2025-03-27&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=16&rft_id=info:doi/10.3389%2Ffimmu.2025.1550405&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6c24734589044af2889e8910f44107fb
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon